Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Hartmann’s Solution for Infusion, PPC PSEB bag
Medicines register · Ireland

Hartmann’s Solution for Infusion, PPC PSEB bag

Authorisation PA2059/057/003 · Fresenius Kabi Deutschland GmbH

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 21 Nov 2026
Licence holder
Fresenius Kabi Deutschland GmbH (all products →)
Active substances
Sodium chloride, Potassium chloride, Calcium chloride dihydrate, Sodium lactate
Clinical trials
3 clinical trials → 3 clinical trials → 2 clinical trials →
Dosage form
Solution for infusion
Route of administration
Intravenous use
ATC codes
B05BB, B05BB01
First authorised
20/05/2005
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Well-established use application (Article 10a of Directive No 2001/83/EC)

Sodium chloride: supply and approvals

126 authorised products on the HPRA list contain Sodium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
Sodium Acetate Injection: in shortage, updated 15 Nov 2026
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Potassium chloride: supply and approvals

68 authorised products on the HPRA list contain Potassium chloride. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
Potassium Chloride Tablet, Extended Release: resolved, updated 21 Nov 2025
Germany (BfArM)
No entry in the BfArM supply notices (checked 20 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

Calcium chloride dihydrate: supply and approvals

55 authorised products on the HPRA list contain Calcium chloride dihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 20 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 20 Nov 2026)
Germany (BfArM)
1 supply notice, e.g. OsvaRen (24 Mar 2025 to 31 Mar 2027)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 21 years (since 20 May 2005). The HPRA list marks it as marketed in Ireland.

Other medicines with Sodium chloride in Ireland

121 other products on the HPRA list contain Sodium chloride, from 22 licence holders; 76 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
0.9 % w/v Sodium Chloride Injection BPB. Braun Melsungen AGNational authorisation (PA)Marketed
Accusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
Accusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
Accusol 35 Solution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
CLINIMIX N14G30E, solution for infusionBaxter Holding B.V.National authorisation (PA)Marketed
Compound Sodium Lactate Intravenous Infusion BP, Solution for Infusion (Hartmann’s Solution)B. Braun Melsungen AGNational authorisation (PA)Marketed
Compound Sodium Lactate Solution for Infusion BPBaxter Holding B.V.National authorisation (PA)Marketed
Dioralyte Blackcurrant Powder for Oral SolutionPhoenix LabsNational authorisation (PA)Marketed
Dioralyte Citrus Powder for Oral SolutionPhoenix LabsNational authorisation (PA)Marketed
Dioralyte Natural, Powder for oral solutionPhoenix LabsNational authorisation (PA)Marketed
Dona 1500 mg Powder for oral solutionCooper Consumer Health B.V.National authorisation (PA)Marketed
EXTRANEAL Solution for peritoneal dialysisVantive Belgium SRLNational authorisation (PA)Marketed

All 122 products with Sodium chloride →

Other medicines with Potassium chloride in Ireland

87 other products on the HPRA list contain Potassium chloride, from 23 licence holders; 56 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Accusol 35 Potassium 2 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
Accusol 35 Potassium 4 mmol/lSolution for haemofiltration, haemodialysis and haemodiafiltrationNikkiso Belgium bvbaNational authorisation (PA)Marketed
Celsior solution for organ preservationInstitut Georges Lopez - IGLNational authorisation (PA)Marketed
Centyl K 2.5 mg/573 mg modified-release tabletsKaro Pharma ABNational authorisation (PA)Marketed
Compound Sodium Lactate Intravenous Infusion BP, Solution for Infusion (Hartmann’s Solution)B. Braun Melsungen AGNational authorisation (PA)Marketed
Compound Sodium Lactate Solution for Infusion BPBaxter Holding B.V.National authorisation (PA)Marketed
Dioralyte Blackcurrant Powder for Oral SolutionPhoenix LabsNational authorisation (PA)Marketed
Dioralyte Citrus Powder for Oral SolutionPhoenix LabsNational authorisation (PA)Marketed
Dioralyte Natural, Powder for oral solutionPhoenix LabsNational authorisation (PA)Marketed
Finomel Emulsion for InfusionBaxter Holding B.V.National authorisation (PA)Marketed
Finomel Peri Emulsion for InfusionBaxter Holding B.V.National authorisation (PA)Marketed
Gelaspan Solution for InfusionB. Braun Melsungen AGNational authorisation (PA)Marketed

All 88 products with Potassium chloride →

Other substances in ATC group B05BB

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 10 other active substances share the group B05BB with this product:

Glucose monohydrate (5) · Sodium acetate trihydrate (4) · Magnesium chloride hexahydrate (4) · Glucose (2) · Sodium gluconate (2) · Sodium lactate solution (1) · Sodium lactate solution 60% (1) · Calciumchloride dihydrate (1) · Sodium hydroxide (1) · Glucose anhydrous (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Fresenius Kabi Deutschland GmbH holds 164 products on the HPRA list, with 164 different active substances; 69 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.